Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician's view.
Carda S, Invernizzi M, Bavikatte G, Bensmaïl D, Bianchi F, Deltombe T, Draulans N, Esquenazi A, Francisco GE, Gross R, Jacinto LJ, Moraleda Pérez S, O'Dell MW, Reebye R, Verduzco-Gutierrez M, Wissel J, Molteni F. Carda S, et al. Among authors: bensmail d. Ann Phys Rehabil Med. 2020 Nov;63(6):554-556. doi: 10.1016/j.rehab.2020.04.001. Epub 2020 Apr 18. Ann Phys Rehabil Med. 2020. PMID: 32315802 Free PMC article. No abstract available.
European consensus table on the use of botulinum toxin type A in adult spasticity.
Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, Schnider P, Altavista MC, Cavazza S, Deltombe T, Duarte E, Geurts AC, Gracies JM, Haboubi NH, Juan FJ, Kasch H, Kätterer C, Kirazli Y, Manganotti P, Parman Y, Paternostro-Sluga T, Petropoulou K, Prempeh R, Rousseaux M, Slawek J, Tieranta N. Wissel J, et al. Among authors: bensmail d. J Rehabil Med. 2009 Jan;41(1):13-25. doi: 10.2340/16501977-0303. J Rehabil Med. 2009. PMID: 19197564 Free article.
Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.
Wissel J, Bensmail D, Ferreira JJ, Molteni F, Satkunam L, Moraleda S, Rekand T, McGuire J, Scheschonka A, Flatau-Baqué B, Simon O, Rochford ET, Dressler D, Simpson DM; TOWER study investigators. Wissel J, et al. Among authors: bensmail d. Neurology. 2017 Apr 4;88(14):1321-1328. doi: 10.1212/WNL.0000000000003789. Epub 2017 Mar 10. Neurology. 2017. PMID: 28283596 Free PMC article.
Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
Marciniak C, McAllister P, Walker H, Brashear A, Edgley S, Deltombe T, Khatkova S, Banach M, Gul F, Vilain C, Picaut P, Grandoulier AS, Gracies JM; International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group. Marciniak C, et al. PM R. 2017 Dec;9(12):1181-1190. doi: 10.1016/j.pmrj.2017.06.007. Epub 2017 Jun 16. PM R. 2017. PMID: 28625615 Free article. Clinical Trial.
Dose-Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study.
O'Dell MW, Brashear A, Jech R, Lejeune T, Marque P, Bensmail D, Ayyoub Z, Simpson DM, Volteau M, Vilain C, Picaut P, Gracies JM. O'Dell MW, et al. Among authors: bensmail d. PM R. 2018 Jan;10(1):1-10. doi: 10.1016/j.pmrj.2017.06.008. Epub 2017 Jun 19. PM R. 2018. PMID: 28634000 Clinical Trial.
Does botulinum toxin treatment improve upper limb active function?
Levy J, Molteni F, Cannaviello G, Lansaman T, Roche N, Bensmail D. Levy J, et al. Among authors: bensmail d. Ann Phys Rehabil Med. 2019 Jul;62(4):234-240. doi: 10.1016/j.rehab.2018.05.1320. Epub 2018 Jun 28. Ann Phys Rehabil Med. 2019. PMID: 29960017 Free article. Review.
142 results